购物车
全部删除
您的购物车当前为空
别名 (R)-1-(2-((2-methoxy-4-(piperazin-1-yl)phenyl)amino)pyridin-4-yl)-N-(4-(trifluoromethoxy)benzyl)piperidine-3-carboxamide hydrochloride(2365497-12-5 Free base)
ALK/ROS1 inhibitor 2e HCL 具有抗凋亡、抗增殖和抗肿瘤活性。

ALK/ROS1 inhibitor 2e HCL 具有抗凋亡、抗增殖和抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 546 | 现货 | |
| 5 mg | ¥ 1,210 | 现货 | |
| 10 mg | ¥ 1,790 | 现货 | |
| 25 mg | ¥ 2,870 | 现货 | |
| 50 mg | ¥ 4,090 | 现货 | |
| 100 mg | ¥ 5,680 | 现货 | |
| 200 mg | ¥ 7,630 | 现货 |
ALK/ROS1 inhibitor 2e HCL 相关产品
| 产品描述 | ALK/ROS1 inhibitor 2e HCL possesses anti-apoptotic, anti-proliferative and anti-tumour activities. |
| 靶点活性 | Ba/F3 cells:104.7 nM, ALK (L1196M):41.3 nM, ALK:174 nM, ROS1:530 nM |
| 体外活性 | (R)-1-(2-((2-甲氧基-4-(哌嗪-1-基)苯基)氨基)吡啶-4-基)-N-(4-(三氟甲氧基)苯基)哌啶-3-羧酰胺 (2e) 在针对临床上对Crizotinib耐药的ALKL1196M表现出显著的酶活性,具有41.3 nM的IC50值。[1] 同时,在携带ROS1G2032R的Ba/F3细胞系中,2e也显示出了强大的抑制活性,其效力约为Crizotinib的6倍(IC50: 104.7 nM vs. 643.5 nM)。[1] |
| 别名 | (R)-1-(2-((2-methoxy-4-(piperazin-1-yl)phenyl)amino)pyridin-4-yl)-N-(4-(trifluoromethoxy)benzyl)piperidine-3-carboxamide hydrochloride(2365497-12-5 Free base) |
| 分子量 | 621.09 |
| 分子式 | C30H36ClF3N6O3 |
| Smiles | O=C([C@H]1CN(C2=CC(NC3=CC=C(N4CCNCC4)C=C3OC)=NC=C2)CCC1)NCC5=CC=C(OC(F)(F)F)C=C5.[H]Cl |
| 密度 | no data available |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (80.5 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容